Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Hien D, Ruglass L. Interpersonal partner violence and women in the United States: an overview of prevalence rates, psychiatric correlates and consequences and barriers to help seeking. Int J Law Psychiatry. 2009 Jan-Feb;32(1):48-55. doi: 10.1016/j.ijlp.2008.11.003. Epub 2008 Dec 19. Review. PubMed PMID: 19101036; PubMed Central PMCID: PMC3468326.
El-Bassel N, Caldeira NA, Ruglass LM, Gilbert L. Addressing the unique needs of African American women in HIV prevention. Am J Public Health. 2009 Jun;99(6):996-1001. doi: 10.2105/AJPH.2008.140541. Epub 2009 Apr 16. PubMed PMID: 19372518; PubMed Central PMCID: PMC2679773.
Hien DA, Campbell AN, Ruglass LM, Hu MC, Killeen T. The role of alcohol misuse in PTSD outcomes for women in community treatment: a secondary analysis of NIDA's Women and Trauma Study. Drug Alcohol Depend. 2010 Sep 1;111(1-2):114-9. doi: 10.1016/j.drugalcdep.2010.04.011. Epub 2010 May 26. PubMed PMID: 20537811; PubMed Central PMCID: PMC2981092.
Burlew AK, Weekes JC, Montgomery L, Feaster DJ, Robbins MS, Rosa CL, Ruglass LM, Venner KL, Wu LT. Conducting research with racial/ethnic minorities: methodological lessons from the NIDA Clinical Trials Network. Am J Drug Alcohol Abuse. 2011 Sep;37(5):324-32. doi: 10.3109/00952990.2011.596973. PubMed PMID: 21854274; PubMed Central PMCID: PMC3445256.
Hien DA, Morgan-Lopez AA, Campbell AN, Saavedra LM, Wu E, Cohen L, Ruglass L, Nunes EV. Attendance and substance use outcomes for the Seeking Safety program: sometimes less is more. J Consult Clin Psychol. 2012 Feb;80(1):29-42. doi: 10.1037/a0026361. Epub 2011 Dec 19. PubMed PMID: 22182262; PubMed Central PMCID: PMC3682930.
Ruglass LM, Miele GM, Hien DA, Campbell AN, Hu MC, Caldeira N, Jiang H, Litt L, Killeen T, Hatch-Maillette M, Najavits L, Brown C, Robinson JA, Brigham GS, Nunes EV. Helping alliance, retention, and treatment outcomes: a secondary analysis from the NIDA Clinical Trials Network Women and Trauma Study. Subst Use Misuse. 2012 May;47(6):695-707. doi: 10.3109/10826084.2012.659789. Epub 2012 Apr 4. PubMed PMID: 22475068; PubMed Central PMCID: PMC3639137.
Morgan-Lopez AA, Saavedra LM, Hien DA, Campbell AN, Wu E, Ruglass L. Synergy between seeking safety and twelve-step affiliation on substance use outcomes for women. J Subst Abuse Treat. 2013 Aug;45(2):179-89. doi: 10.1016/j.jsat.2013.01.015. Epub 2013 Apr 1. PubMed PMID: 23558158; PubMed Central PMCID: PMC4153737.
Ruglass LM, Hien DA, Hu MC, Campbell AN. Associations between post-traumatic stress symptoms, stimulant use, and treatment outcomes: a secondary analysis of NIDA's Women and Trauma study. Am J Addict. 2014 Jan-Feb;23(1):90-5. doi: 10.1111/j.1521-0391.2013.12068.x. Epub 2013 Jun 26. PubMed PMID: 24313246; PubMed Central PMCID: PMC3857558.
Morgan-Lopez AA, Saavedra LM, Hien DA, Campbell AN, Wu E, Ruglass L, Patock-Peckham JA, Bainter SC. Indirect effects of 12-session seeking safety on substance use outcomes: overall and attendance class-specific effects. Am J Addict. 2014 May-Jun;23(3):218-25. doi: 10.1111/j.1521-0391.2014.12100.x. PubMed PMID: 24724878.
Ruglass LM, Hien DA, Hu MC, Campbell AN, Caldeira NA, Miele GM, Chang DF. Racial/ethnic match and treatment outcomes for women with PTSD and substance use disorders receiving community-based treatment. Community Ment Health J. 2014 Oct;50(7):811-22. doi: 10.1007/s10597-014-9732-9. Epub 2014 May 10. PubMed PMID: 24817203; PubMed Central PMCID: PMC4175006.
Ruglass LM, Papini S, Trub L, Hien DA. Psychometric Properties of the Modified Posttraumatic Stress Disorder Symptom Scale among Women with Posttraumatic Stress Disorder and Substance Use Disorders Receiving Outpatient Group Treatments. J Trauma Stress Disord Treat. 2014;4(1). doi: 10.4172/2324-8947.1000139. Epub 2014 Oct 28. PubMed PMID: 26543877; PubMed Central PMCID: PMC4631264.
Ruglass LM, Lopez-Castro T, Cheref S, Papini S, Hien DA. At the crossroads: the intersection of substance use disorders, anxiety disorders, and posttraumatic stress disorder. Curr Psychiatry Rep. 2014 Nov;16(11):505. doi: 10.1007/s11920-014-0505-5. Review. PubMed PMID: 25224608.
Hien DA, Levin FR, Ruglass LM, López-Castro T, Papini S, Hu MC, Cohen LR, Herron A. Combining seeking safety with sertraline for PTSD and alcohol use disorders: A randomized controlled trial. J Consult Clin Psychol. 2015 Apr;83(2):359-69. doi: 10.1037/a0038719. Epub 2015 Jan 26. PubMed PMID: 25622199; PubMed Central PMCID: PMC4380540.
López-Castro T, Hu MC, Papini S, Ruglass LM, Hien DA. Pathways to change: Use trajectories following trauma-informed treatment of women with co-occurring post-traumatic stress disorder and substance use disorders. Drug Alcohol Rev. 2015 May;34(3):242-51. doi: 10.1111/dar.12230. Epub 2015 Mar 4. PubMed PMID: 25735200; PubMed Central PMCID: PMC7678790.
McClure EA, Campbell AN, Pavlicova M, Hu M, Winhusen T, Vandrey RG, Ruglass LM, Covey LS, Stitzer ML, Kyle TL, Nunes EV. Cigarette Smoking During Substance Use Disorder Treatment: Secondary Outcomes from a National Drug Abuse Treatment Clinical Trials Network study. J Subst Abuse Treat. 2015 Jun;53:39-46. doi: 10.1016/j.jsat.2014.12.007. Epub 2014 Dec 30. PubMed PMID: 25595301; PubMed Central PMCID: PMC4414703.
Hien DA, Campbell AN, Ruglass LM, Saavedra L, Mathews AG, Kiriakos G, Morgan-Lopez A. Maximizing Effectiveness Trials in PTSD and SUD Through Secondary Analysis: Benefits and Limitations Using the National Institute on Drug Abuse Clinical Trials Network "Women and Trauma" Study as a Case Example. J Subst Abuse Treat. 2015 Sep;56:23-33. doi: 10.1016/j.jsat.2015.04.001. Epub 2015 Apr 7. PubMed PMID: 25907849; PubMed Central PMCID: PMC4519371.
Fertuck EA, Tsoi F, Grinband J, Ruglass L, Melara R, Hien DA. Facial trustworthiness perception bias elevated in individuals with PTSD compared to trauma exposed controls. Psychiatry Res. 2016 Mar 30;237:43-8. doi: 10.1016/j.psychres.2016.01.056. Epub 2016 Jan 27. PubMed PMID: 26921050.
Ruglass LM, Espinosa A, Sykes KM, Shevorykin A, Nicholson R, Dambreville N. Direct and indirect effects of cumulative trauma on history of arrest among lower SES African American and Latina women. Race and justice. 2016 June; 8(2):126-153. doi: 10.1177/2153368716656917.
Ruglass LM, Pedersen A, Cheref S, Hu MC, Hien DA. Racial differences in adherence and response to combined treatment for full and subthreshold post-traumatic stress disorder and alcohol use disorders: A secondary analysis. J Ethn Subst Abuse. 2016 Oct-Dec;15(4):434-448. doi: 10.1080/15332640.2015.1056927. Epub 2015 Sep 30. PubMed PMID: 26422415; PubMed Central PMCID: PMC5581661.
Papini S, Ruglass LM, Lopez-Castro T, Powers MB, Smits JA, Hien DA. Chronic cannabis use is associated with impaired fear extinction in humans. J Abnorm Psychol. 2017 Jan;126(1):117-124. doi: 10.1037/abn0000224. Epub 2016 Nov 3. PubMed PMID: 27808542; NIHMSID:NIHMS1879590.
Ruglass LM, Shevorykin A, Radoncic V, Smith KM, Smith PH, Galatzer-Levy IR, Papini S, Hien DA. Impact of Cannabis Use on Treatment Outcomes among Adults Receiving Cognitive-Behavioral Treatment for PTSD and Substance Use Disorders. J Clin Med. 2017 Feb 7;6(2). doi: 10.3390/jcm6020014. PubMed PMID: 28178207; PubMed Central PMCID: PMC5332918.
Ruglass LM, Lopez-Castro T, Papini S, Killeen T, Back SE, Hien DA. Concurrent Treatment with Prolonged Exposure for Co-Occurring Full or Subthreshold Posttraumatic Stress Disorder and Substance Use Disorders: A Randomized Clinical Trial. Psychother Psychosom. 2017;86(3):150-161. doi: 10.1159/000462977. Epub 2017 May 11. PubMed PMID: 28490022; PubMed Central PMCID: PMC5610572.
Espinosa A, Ruglass LM, Dambreville N, Shevorykin A, Nicholson R, Sykes KM. Correlates of child abuse potential among African American and latina mothers: A developmental-ecological perspective. Child Abuse Negl. 2017 Aug;70:222-230. doi: 10.1016/j.chiabu.2017.06.003. Epub 2017 Jun 16. PubMed PMID: 28628899.
Ruglass LM, Shevorykin A, Brezing C, Hu MC, Hien DA. Demographic and clinical characteristics of treatment seeking women with full and subthreshold PTSD and concurrent cannabis and cocaine use disorders. J Subst Abuse Treat. 2017 Sep;80:45-51. doi: 10.1016/j.jsat.2017.06.007. Epub 2017 Jun 28. PubMed PMID: 28755772; PubMed Central PMCID: PMC5575989.
Jones JD, Manubay JM, Mogali S, Metz VE, Madera G, Martinez S, Mumtaz M, Comer SD. Abuse liability of intravenous buprenorphine vs. buprenorphine/naloxone: Importance of absolute naloxone amount. Drug Alcohol Depend. 2017 Oct 1;179:362-369. doi: 10.1016/j.drugalcdep.2017.06.033. Epub 2017 Jul 26. PubMed PMID: 28844013; PubMed Central PMCID: PMC10071507.
Hien DA, Lopez-Castro T, Papini S, Gorman B, Ruglass LM. Emotion dysregulation moderates the effect of cognitive behavior therapy with prolonged exposure for co-occurring PTSD and substance use disorders. J Anxiety Disord. 2017 Dec;52:53-61. doi: 10.1016/j.janxdis.2017.10.003. Epub 2017 Oct 16. PubMed PMID: 29049902; PubMed Central PMCID: PMC5728385.
Jones JD, Comer SD, Metz VE, Manubay JM, Mogali S, Ciccocioppo R, Martinez S, Mumtaz M, Bisaga A. Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential. Pharmacol Biochem Behav. 2017 Dec;163:90-100. doi: 10.1016/j.pbb.2017.10.002. Epub 2017 Oct 8. PubMed PMID: 29020601; PubMed Central PMCID: PMC5959043.
Melara RD, Ruglass LM, Fertuck EA, Hien DA. Regulation of threat in post-traumatic stress disorder: Associations between inhibitory control and dissociative symptoms. Biol Psychol. 2018 Mar;133:89-98. doi: 10.1016/j.biopsycho.2018.01.017. Epub 2018 Feb 1. PubMed PMID: 29409740.
Hien DA, Smith KZ, Owens M, López-Castro T, Ruglass LM, Papini S. Lagged effects of substance use on PTSD severity in a randomized controlled trial with modified prolonged exposure and relapse prevention. J Consult Clin Psychol. 2018 Oct;86(10):810-819. doi: 10.1037/ccp0000345. PubMed PMID: 30265040; PubMed Central PMCID: PMC6540990.
Ruglass LM, Shevorykin A, Dambreville N, Melara RD. Neural and behavioral correlates of attentional bias to cannabis cues among adults with cannabis use disorders. Psychol Addict Behav. 2019 Feb;33(1):69-80. doi: 10.1037/adb0000423. Epub 2018 Dec 27. PubMed PMID: 30589308.
Ruglass LM, Yali AM. Do race/ethnicity and religious affiliation moderate treatment outcomes among individuals with co-occurring PTSD and substance use disorders?. J Prev Interv Community. 2019 Jul-Sep;47(3):198-213. doi: 10.1080/10852352.2019.1603674. Epub 2019 May 11. PubMed PMID: 31081480; PubMed Central PMCID: PMC7034879.
Shevorykin A, Ruglass LM, Melara RD. Frontal Alpha Asymmetry and Inhibitory Control among Individuals with Cannabis Use Disorders. Brain Sci. 2019 Aug 29;9(9). doi: 10.3390/brainsci9090219. PubMed PMID: 31470590; PubMed Central PMCID: PMC6770848.
Jones JD, Mumtaz M, Manubay JM, Mogali S, Sherwin E, Martinez S, Comer SD. Assessing the contribution of opioid- and dopamine-related genetic polymorphisms to the abuse liability of oxycodone. Pharmacol Biochem Behav. 2019 Nov;186:172778. doi: 10.1016/j.pbb.2019.172778. Epub 2019 Sep 4. PubMed PMID: 31493434; PubMed Central PMCID: PMC6801039.
Ruglass LM, Scodes J, Pavlicova M, Campbell ANC, Fitzpatrick S, Barbosa-Leiker C, Burlew K, Greenfield SF, Rotrosen J, Nunes EV Jr. Trajectory classes of opioid use among individuals in a randomized controlled trial comparing extended-release naltrexone and buprenorphine-naloxone. Drug Alcohol Depend. 2019 Dec 1;205:107649. doi: 10.1016/j.drugalcdep.2019.107649. Epub 2019 Oct 21. PubMed PMID: 31704382; PubMed Central PMCID: PMC6990451.
Ruglass LM, Root JC, Dambreville N, Shevorykin A, Haque N, Sun V, Sheffer CE, Melara RD. Smoking policies in the home have less influence on cigarettes per day and nicotine dependence level among African American than White smokers: A cross-sectional analysis. J Natl Med Assoc. 2019 Dec;111(6):606-615. doi: 10.1016/j.jnma.2019.07.002. Epub 2019 Jul 30. PubMed PMID: 31375277; PubMed Central PMCID: PMC6925645.
Ruglass LM, Espinosa A, Fitzpatrick S, Meyer MK, Cadet K, Sokolovsky A, Jackson KM, White HR. Prevalence and Correlates of Concurrent and Simultaneous Cannabis and Cigarette Use among Past-Year Cannabis-Using US College Students. Subst Use Misuse. 2020;55(2):329-336. doi: 10.1080/10826084.2019.1668015. Epub 2019 Oct 1. PubMed PMID: 31573377; PubMed Central PMCID: PMC6980755.
Hien D, Kropp F, Wells EA, Campbell A, Hatch-Maillette M, Hodgkins C, Killeen T, Lopez-Castro T, Morgan-Lopez A, Ruglass LM, Saavedra L, Nunes EV. The "Women and Trauma" study and its national impact on advancing trauma specific approaches in community substance use treatment and research. J Subst Abuse Treat. 2020 Mar;112S:12-17. doi: 10.1016/j.jsat.2020.02.003. PubMed PMID: 32220405; PubMed Central PMCID: PMC7123457.
Brandt L, Jones JD, Martinez S, Manubay JM, Mogali S, Ramey T, Levin FR, Comer SD. Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder. Drug Alcohol Depend. 2020 Mar 1;208:107859. doi: 10.1016/j.drugalcdep.2020.107859. Epub 2020 Jan 17. PubMed PMID: 31980285; PubMed Central PMCID: PMC7063580.
Morgan-López AA, Saavedra LM, Hien DA, Killeen TK, Back SE, Ruglass LM, Fitzpatrick S, López-Castro T, Patock-Peckham JA. Estimation of equable scale scores and treatment outcomes from patient- and clinician-reported PTSD measures using item response theory calibration. Psychol Assess. 2020 Apr;32(4):321-335. doi: 10.1037/pas0000789. Epub 2019 Dec 5. PubMed PMID: 31804102.
Saraiya TC, Swarbrick M, Franklin L, Kass S, Campbell ANC, Hien DA. Perspectives on trauma and the design of a technology-based trauma-informed intervention for women receiving medications for addiction treatment in community-based settings. J Subst Abuse Treat. 2020 May;112:92-101. doi: 10.1016/j.jsat.2020.01.011. Epub 2020 Jan 25. PubMed PMID: 32199551; NIHMSID:NIHMS1978798.
Fitzpatrick S, Saraiya T, Lopez-Castro T, Ruglass LM, Hien D. The impact of trauma characteristics on post-traumatic stress disorder and substance use disorder outcomes across integrated and substance use treatments. J Subst Abuse Treat. 2020 Jun;113:107976. doi: 10.1016/j.jsat.2020.01.012. Epub 2020 Jan 22. PubMed PMID: 32059924; PubMed Central PMCID: PMC7198321.
Morgan-López AA, Killeen TK, Saavedra LM, Hien DA, Fitzpatrick S, Ruglass LM, Back SE. Crossover between diagnostic and empirical categorizations of full and subthreshold PTSD. J Affect Disord. 2020 Sep 1;274:832-840. doi: 10.1016/j.jad.2020.05.031. Epub 2020 May 24. PubMed PMID: 32664022; PubMed Central PMCID: PMC7388200.
Ruglass LM, Root JC, Dambreville N, Shevorykin A, Sheffer CE, Melara RD. Examining differences in attentional bias to smoking-related cues among black and white cigarette smokers: An event-related potential pilot study. Neurosci Lett. 2020 Sep 14;735:135241. doi: 10.1016/j.neulet.2020.135241. Epub 2020 Jul 10. PubMed PMID: 32659312; PubMed Central PMCID: PMC8075105.
Ruglass LM, Morgan-López AA, Saavedra LM, Hien DA, Fitzpatrick S, Killeen TK, Back SE, López-Castro T. Measurement nonequivalence of the Clinician-Administered PTSD Scale by race/ethnicity: Implications for quantifying posttraumatic stress disorder severity. Psychol Assess. 2020 Nov;32(11):1015-1027. doi: 10.1037/pas0000943. Epub 2020 Aug 27. PubMed PMID: 32853005; PubMed Central PMCID: PMC8136270.
Allan NP, López-Castro T, Hien DA, Papini S, Killeen TK, Gros DF, Ruglass LM, Barrett E, Back SE. Response-to-Treatment for Comorbid Post-Traumatic Stress and Substance Use Disorders: The Value of Combining Person- and Variable-Centered Approaches. J Psychopathol Behav Assess. 2020 Dec;42(4):725-738. doi: 10.1007/s10862-020-09803-w. Epub 2020 Apr 28. PubMed PMID: 33239837; PubMed Central PMCID: PMC7682732.
Martinez S, Jones JD, Brandt L, Campbell ANC, Abbott R, Comer SD. The Increasing Prevalence of Fentanyl: A Urinalysis-Based Study Among Individuals With Opioid Use Disorder in New York City. Am J Addict. 2021 Jan;30(1):65-71. doi: 10.1111/ajad.13092. Epub 2020 Aug 10. PubMed PMID: 32776640; PubMed Central PMCID: PMC7816517.
Saraiya TC, Fitzpatrick S, Zumberg-Smith K, López-Castro T, E Back S, A Hien D. Social-Emotional Profiles of PTSD, Complex PTSD, and Borderline Personality Disorder Among Racially and Ethnically Diverse Young Adults: A Latent Class Analysis. J Trauma Stress. 2021 Feb;34(1):56-68. doi: 10.1002/jts.22590. Epub 2020 Oct 1. PubMed PMID: 33006199; PubMed Central PMCID: PMC9817088.
Saavedra LM, Morgan-López AA, Hien DA, Killeen TK, Back SE, Ruglass LM, Fitzpatrick S, Lopez-Castro T. Putting the Patient Back in Clinical Significance: Moderated Nonlinear Factor Analysis for Estimating Clinically Significant Change in Treatment for Posttraumatic Stress Disorder. J Trauma Stress. 2021 Apr;34(2):454-466. doi: 10.1002/jts.22624. Epub 2020 Nov 11. PubMed PMID: 33175470.
Martinez S, Jones JD, Brandt L, Hien D, Campbell ANC, Batchelder S, Comer SD. Factor structure and psychometric properties of the Connor-Davidson resilience scale (CD-RISC) in individuals with opioid use disorder. Drug Alcohol Depend. 2021 Apr 1;221:108632. doi: 10.1016/j.drugalcdep.2021.108632. Epub 2021 Feb 16. PubMed PMID: 33621807; PubMed Central PMCID: PMC8026692.
Martinez S, Jones JD, Vadhan NP, Brandt L, Comer SD, Bisaga A. The acute and repeated effects of cigarette smoking and smoking-related cues on impulsivity. Drug Alcohol Rev. 2021 Jul;40(5):864-868. doi: 10.1111/dar.13206. Epub 2020 Nov 2. PubMed PMID: 33140460; PubMed Central PMCID: PMC8088442.
What would you like to do?